BioNTech BNT162 COVID-19 Vaccine
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency | SpringerLink
Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study
How Moderna's Covid-19 Vaccine Works - The New York Times
mRNA vaccine for cancer immunotherapy | Molecular Cancer | Full Text
Results of Pfizer COVID-19 mRNA Vaccine Phase 1/2 Study
mRNA vaccines against COVID-19: Pfizer-BioNTech COVID-19 vaccine BNT162b2: prepared by the Strategic Advisory Group of Experts (SAGE) on immunization working group on COVID-19 vaccines, 22 December 2020
This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines | Science | AAAS
BioNTech SE on Twitter: "+++Omicron BA.1-adapted bivalent vaccine update+++ Our BA.1 Bivalent COVID-19 Vaccine was recommended for conditional marketing authorization by @EMA_News' Committee for Medicinal Products for Human Use as a booster
Dekonstruktion des Programmcodes des BioNTech/Pfizer SARS-CoV-2 Impfstoffes - Bert Hubert's writings
RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation - YouTube
SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency | Signal Transduction and Targeted Therapy
COVID-19 mRNA vaccines: Platforms and current developments - ScienceDirect
IJMS | Free Full-Text | mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
How mRNA Vaccines Might Help Treat Cancer - NCI
RACGP - Four things about mRNA vaccines researchers still want to find out
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
COVID-19 mRNA vaccines: Platforms and current developments: Molecular Therapy
mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19
